bioRxiv / medRxiv
open access
CC BY-NC-ND 4.0
Intranasal CRISPR- lipid nanoparticles targeting MAPK9 reduce neuroinflammation after traumatic brain injury
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Microglia-Targeted PAMAM Dendrimers for Nucleic Acid Delivery in Brain Injury Application#983528
- Artificial intelligence-guided nanozyme engineering for chronic wound healing: from rational design to precision therapeutics.#923381
- Image 1_Neutrophil-hitchhiking nanoplatform overcomes blood–brain barrier to treat cerebral ischemia-reperfusion injury via ferroptosis inhibition and microglial modulation.jpeg#408507
- Enhanced proofreading governs CRISPR–Cas9 targeting accuracy#614687
- Blockade of Neuroglobin Reduces Protection of Conditioned Medium from Human Mesenchymal Stem Cells in Human Astrocyte Model (T98G) Under a Scratch Assay#947748
Record · ID 223924
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive